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Abstract
DNA origami, a method for constructing nanoscale objects, relies on a long single strand of DNA to act as the ‘scaffold’ to
template assembly of numerous short DNA oligonucleotide ‘staples’. The ability to generate custom scaffold sequences can
greatly benefit DNA origami design processes. Custom scaffold sequences can provide better control of the overall size of
the final object and better control of low-level structural details, such as locations of specific base pairs within an object.
Filamentous bacteriophages and related phagemids can work well as sources of custom scaffold DNA. However, scaffolds
derived from phages require inclusion of multi-kilobase DNA sequences in order to grow in host bacteria, and those sequen-
ces cannot be altered or removed. These fixed-sequence regions constrain the design possibilities of DNA origami. Here, we
report the construction of a novel phagemid, pScaf, to produce scaffolds that have a custom sequence with a much smaller
fixed region of 393 bases. We used pScaf to generate new scaffolds ranging in size from 1512 to 10 080 bases and demon-
strated their use in various DNA origami shapes and assemblies. We anticipate our pScaf phagemid will enhance develop-
ment of the DNA origami method and its future applications.
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1. Introduction
DNA origami builds tiny shapes using long single-stranded DNA
(ssDNA) scaffolds and short ssDNA staples (1). A key strength of
this method is that one scaffold sequence can be reused with
different staples to create many different shapes (Figure 1A).
However, although shapes generated from a single scaffold se-
quence can vary in nanometer-scale geometry, it is difficult to
engineer sub-nanometer-scale details of shapes using only a
single scaffold, or to create structures that vary in size from a
single scaffold precursor (4). Thus, it is important to generate
new scaffolds to expand the space of possible DNA origami
designs. For example, new scaffolds could help create larger
structures, or shapes with novel multimeric assemblies, or
could help elucidate the principles of DNA origami self-
assembly (Figure 1B). Here, our goal was to create new scaffolds
of almost arbitrary custom sequence, up to 10 kilobases (kb)
long, which are suitable for production in milligram (mg)
quantities.
Many methods for producing scaffolds of custom sequence
have been reported previously (5–19). Typically, ssDNA scaffolds
are derived from double-stranded DNA (dsDNA) sources via
combinations of selective amplification, isolation or degrada-
tion of one of the two strands. While reported methods offer ex-
cellent sequence customizability, they can be difficult to scale
up in sequence length and production yield due to limitations
in various in vitro enzymatic processing steps. We set out to de-
velop a general approach for easily generating new scaffolds
that would be scalable in both length and production yield, thus
overcoming a significant hurdle in expanding their usability.
We selected filamentous bacteriophages as a platform that
offers mg-scale yields in shake flasks, and whose yield can be
boosted with bioreactors if needed (20). Filamentous phages,
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such as M13, are bacteria-specific viruses that package and ex-
port their single-stranded genomes into rod-like particles that
have a protein coat. The phages can be recovered from the cul-
ture media and the ssDNA purified by standard molecular biol-
ogy techniques (21). Custom sequences up to 2.5 kb can be
inserted reliably into the M13 genome (22), though schemes to
create much longer scaffolds have been reported (11). However,
sequence customizability in the M13 phage is limited because
most of its genome (>6 kb) consists of protein-coding and regu-
latory sequences that cannot be easily modified without dis-
rupting phage growth.
Phagemids can be used to create scaffolds that have im-
proved sequence customizability compared to M13 (9, 17, 23).
These plasmids typically contain a host origin of replication
(ori) sequence, a phage ori from M13 or relative such as f1, and
an antibiotic resistance gene. Phagemid ssDNA can be exported
in phage-like particles if the host cell is co-infected with a
‘helper phage’ or transformed with a ‘helper plasmid’ to express
the necessary viral proteins (24). Phagemids can accommodate
custom inserts several kb in size, but include a 2–3 kb fixed re-
gion that limits their usefulness in producing custom origami
scaffolds (Figure 1C).
To increase scaffold sequence customizability, we sought to
create a phagemid that could be produced using established
preparation methods but would be able to package and export
custom ssDNA sequences that have a relatively small fixed re-
gion. We were inspired by two papers that reported making use
of modified f1-ori sequences to manipulate ssDNA synthesis
(Figure 1D and E). In 1982, Dotto et al. (2) used phagemids with
modified origins to show that f1-ori ssDNA synthesis initiation
and termination functions overlap, but can be inactivated sepa-
rately by modifying distinct sequences. In 1992, Specthrie et al.
(3) packaged ssDNA as short as 292 bases into phage-like par-
ticles they called microphages. They were able to build small
ssDNA strands using a phagemid that included an f1-ori, a
packaging sequence (PS) and a truncated f1-ori that acts as a
terminator (f1-oriD29). The terminator interrupts ssDNA syn-
thesis of the full phagemid sequence, leading to packaging and
export of only the region flanked by the ori and terminator.
We constructed a new phagemid, pScaf, for making custom
DNA origami ssDNA scaffolds. After optimizing the pScaf
ssDNA synthesis terminator, we used an iterative restriction-
enzyme digestion and ligation scheme to clone several se-
quence inserts to produce scaffolds ranging from 1512 to 10080
bases in total length, each including an identical 393-base fixed
region. We designed and folded several DNA origami shapes us-
ing the custom scaffolds, including a one-pot assembly of three
scaffolds into a six-helix-bundle trimer, and analyzed the fold-
ing quality by gel and negative stain transmission electron mi-
croscopy (TEM).
Figure 1. DNA origami design would benefit from custom scaffolds. (A) Many DNA origami shapes can be folded from a single scaffold. (B) New scaffolds will expand
the space of possible designs. (C) Phagemids are excellent sources of scaffolds, but have multi-kilobase sequence constraints. Previous studies offer hints of how these
constraints could be circumvented. (D) Dotto et al. (2) used phagemids with modified origins to show that f1-ori ssDNA initiation and termination functions overlap,
but can be inactivated separately by modifying distinct sequences. (E) Specthrie et al. (3) produced phage-like particles with ssDNA as short as 292 bases using a trun-
cated f1-ori that acts as a terminator (f1-oriD29).
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2. Materials and methods
2.1 Construction of the pScaf vector
We initially converted the pUC18 vector into a phagemid by
cloning the M13 origin from M13mp18 at the NdeI and KpnI re-
striction sites. Digested fragments were ligated with T4 DNA li-
gase (New England Biolabs (NEB)) and transformed into XL1-
Blue MR competent cells (Agilent). We grew the pUC18-M13ori
phagemid and recovered the DNA with a miniprep. Next, we
used M13mp18 as a template to polymerase chain reaction
(PCR)-amplify the ssDNA synthesis terminator, based on the
D29 design from Specthrie et al. (3) The terminator was then
inserted into the BamHI and EcoRI sites of the pUC18-M13ori.
All subsequent variants of the terminator (Figure 1) were assem-
bled by PCR and cloned into the same BamHI and EcoRI sites,
and verified for correctness using DNA sequencing. We used the
variant with three thymine bases (TTT) as the final pScaf vector
in all subsequent experiments in this work.
2.2 Cloning scheme
We used KpnI and BamHI restriction sites between the ssDNA
synthesis initiator and terminator regions to clone inserts into
the pScaf vector (Figure 3). In one step, we cloned short PCR-
amplified insert sequences (A, B, C) directly into pScaf vectors
that then generated the three smallest scaffolds (1512, 2268 and
3024). To create longer custom scaffolds, we adapted a multi-step
cloning scheme previously used for cloning repeat protein cDNA
constructs (25). We amplified custom sequence inserts in a PCR
using forward and reverse primers designed to incorporate into
the product a 50 KpnI and BglII site, and a 30 BamHI site, respec-
tively. We cloned PCR-amplified sequence inserts of lengths up
to 2.5 kb into separate pScaf vectors (D–L). To combine two inserts
to create one larger insert, we digested the pScaf vector contain-
ing the intended 50 region with PvuI and BamHI, and digested the
vector containing the intended 30 region with PvuI and BglII.
BamHI and BglII digestions create compatible sticky-end over-
hangs that can be used to ligate the two inserts. The bases adja-
cent to the compatible sticky ends are different, so the ligation
product does not reconstitute an internal BamHI or BglII site.
However, the ligated fragment maintains a 50 BglII site and a 30
BamHI site for subsequent cloning rounds. We digest each plas-
mid at the PvuI restriction site to split the ampicillin-resistance
gene bla into two parts that are only reconstituted by successful
ligation of the full-length product. Thus, we generated three vec-
tors with tandem inserts (DE, FG and IJ), and then combined FG
with H to create FGH. We combined IJ with K to create IJK, which
was subsequently combined with L to create IJKL. The pScaf vec-
tors containing inserts DE, FGH and IJKL were then ready to pro-
duce the larger scaffolds (5544, 8064 and 10080).
2.3 Scaffold amplification and purification
We transformed XL1-Blue-MRF’ using the M13cp helper plasmid
(24) and then made it chemically competent with transformation
and storage solution (10% polyethylene glycol (PEG)-8000, 30 mM
MgCl2, 5% dimethyl sulfoxide, in 2xYT, pH 6, filtered) in order to
produce a competent XL1-Blue-Helper strain. XL1-Blue-Helper
was transformed with the desired pScaf construct to create a
custom-phage-producing strain. We selected and grew a single
colony for 18 h in an incubator-shaker (30C, 225 rpm) in 3-mL
2xYT media (1.6% tryptone, 1% yeast extract, 0.25% NaCl) con-
taining kanamycin, carbenicillin and chloramphenicol.
Subsequently, the culture was transferred to a shake flask
containing 100 mL 2xYT, 10 mL phosphate buffer (7% potassium
phosphate dibasic, 3% sodium phosphate monobasic, pH 7, auto-
claved), 1 mL 50% glucose, 0.5 mL 1 M MgCl2 and the appropriate
antibiotics. The flask was then grown for 24 h on a shaker (30C,
225 rpm). The flask was harvested by transferring the culture to a
500-mL ultracentrifuge bottle, stored on ice for 30 min and then
centrifuged at 7000 g for 15 min at 4C, pelleting the bacteria
while allowing the phage to remain in the supernatant. The
phage-containing supernatant was transferred to a clean 500-mL
ultracentrifuge bottle, where 4 g PEG-8000 and 3 g NaCl were
added. The bottle was then incubated on ice for 30 min prior to
centrifugation at 9000 g for 15 min at 4C, allowing the phage to
form a pellet. The supernatant waste was decanted, and the
phage pellet was resuspended in 3 mL Tris EDTA (TE) buffer. The
bottle was then centrifuged at 15 000 g for 15 min at 4C to pellet
any residual bacteria. The supernatant containing the concen-
trated phage was then transferred to a 50-mL ultracentrifuge
tube. Six microliter lysis buffer (0.2 M NaOH, 1% sodium dodecyl
sulfate) was added, and the tube was mixed. Next, 4.5 mL neutral-
ization buffer (3 M KOAc, pH 5.5) was added, and the tube was
again mixed. The tube was incubated on ice for 15 min and then
centrifuged at 15 000 g for 15 min at 4C. The resulting superna-
tant was then decanted into a new 50-mL ultracentrifuge tube
and 27 mL pure ethanol was added to it. The tube was capped
and mixed by inversion prior to incubation at 20C for 18 h.
After incubation, the tube was centrifuged at 16 000 g for 15 min
at 4C to pellet the DNA. The supernatant waste was decanted
leaving the DNA pellet at the bottom of the tube. The pellet was
washed with 9 mL ice-cold 70% ethanol and centrifuged at
16 000 g for 5 min at 4C. The supernatant waste was again deca-
nted. The pellet was subsequently dried by gently blowing air
into the tube, and finally the dried pellet was resuspended in up
to 1 mL TE, depending on the desired concentration.
2.4 DNA origami preparation
Custom scaffold and staples were mixed at final concentrations
of 20 nM and 200 nM, respectively, in a buffer containing 5 mM
Tris, 1 mM ethylenediaminetetraacetic acid (EDTA) and 13 mM
MgCl2. The solution was then subject to the following tempera-
ture ramp: denaturation at 65C for 15 min, followed by cooling
from 60C to 38C with a decrease of 1C per 50 min.
2.5 Agarose gel analysis
Purified scaffolds and folded origami products were analyzed us-
ing 2% agarose gel electrophoresis in Tris-borate-EDTA (45 mM
tris-borate and 1 mM EDTA) supplemented with 11 mM MgCl2 and
SYBR Safe. Upon sample-loading, gels were run for 2 h at 80 V and
subsequently scanned using a Typhoon FLA imager. DNA origami
products folded from 1512-, 2268- and 3024-base scaffolds were
subsequently purified by extracting the desired gel band using a
razor blade, muddled to break down the agarose and then centri-
fuged through a Freeze ‘N Squeeze column (Bio-Rad).
2.6 PEG purification
DNA origami products folded from scaffolds of 5544 bases, and
larger were purified using PEG precipitation. Assembly products
were mixed with an equal volume of PEG precipitation buffer
(15% PEG-8000, 10 mM Tris, 20 mM MgCl2 and 500 mM NaCl) and
immediately centrifuged at 16 000 g at 20C for 25 min. The su-
pernatant was removed, and the pellet (which is often invisible)
was resuspended in 1 folding buffer with magnesium (5 mM
Tris, 1 mM EDTA and 13 mM MgCl2).
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2.7 Transmission electron microscopy
Purified origami structures were diluted to approximately 25 ng/lL
prior to imaging. 5 lL of the diluted origami was applied to
glow-discharged, carbon-coated, 400-mesh formvar grids (Ted
Pella) for 1.5 min. The grid was then blotted dry on filter paper
(Whatman). Washing and staining was performed by preparing
a pierce of parafilm with two 15-lL droplets of 1 folding buffer
and two 15-lL droplets of 2% aqueous uranyl formate (electron
microscopy sciences (EMS)) stain solution. The grid was dipped
onto the first buffer droplet, blotted dry, dipped onto the next
buffer droplet, blotted dry, dipped onto the first stain droplet,
blotted dry, and then held onto the final stain droplet for 45 s
before being blotted dry. Grids were then allowed to air-dry for
10 min prior to imaging. Electron micrographs were collected
using an FEI TECNAI T12 transmission electron microscope us-
ing a using a 4k 4k charge-coupled device camera (UltraScan
4000, Gatan) at 26 000 and 52 000 magnifications. Class aver-
ages were obtained using EMAN2 software.
3. Results
We constructed a phagemid, pScaf that can be used to create
custom DNA origami scaffolds (Figure 2). We converted pUC18
into a phagemid for custom ssDNA production by adding four
components: a full-length M13 origin for ssDNA initiation, KpnI
and BamHI restriction sites for insert cloning, the M13 PS for
phage particle export, and a modified M13 origin to serve as the
ssDNA synthesis terminator (Supplementary Figure S1).
The works by Dotto and Specthrie informed the design and
optimization of pScaf. We reasoned that if a terminator se-
quence can be used to generate microphages, a similar
approach could be used to package larger custom sequences.
We started with a construct that was similar to the Specthire
microphage, except we added a restriction site and custom se-
quence inserts upstream of the terminator. When we tested the
‘D29’ terminator used by Specthrie et al. (3), we were able to pro-
duce our desired custom ssDNA scaffolds. However, our phage
cultures also yielded an off-target ssDNA species consistent in
size with residual packaging of the region downstream of our
custom insert. We suspected that the D29 terminator might not
fully abolish initiation of ssDNA synthesis, resulting in multiple
ssDNA species produced from a single phagemid similar to con-
structs reported by Dotto et al. (2). Thus, we sought to optimize
the terminator to reduce spurious initiation and produce a more
pure ssDNA scaffold product (Figure 2).
Our goal was to optimize the phagemid so it would initiate
ssDNA scaffold synthesis at only one start site (see S1 in
Figure 2A, top left), continue synthesis through any custom
inserted sequence, followed by the packaging site (PS) and fi-
nally end ssDNA synthesis at the termination site (T1 in
Figure 2A, top-right). To minimize the synthesis of a second
ssDNA fragment, we needed to reduce the activity of the second
start site (S2) immediately following T1, which would produce
an extra fragment that ends at the second terminator T2.
3.1 Terminator optimization
We started by truncating the last 50 bases of the 381-base M13
ori sequence so it included the core origin of plus-strand repli-
cation (a,b, c and d regions), but omitted the downstream initia-
tion enhancer region. In his 1997 review, Horiuchi noted the
enhancer can be removed without interfering with termination
Figure 2. Construction and optimization of the pScaf phagemid. (A) The pScaf phagemid is derived from the pUC18 plasmid and M13mp18 phage vectors. The phage-
mid includes an M13 origin of replication (M13ori) that contains ssDNA start site S1 and ssDNA termination site T2, a KpnI and BamHI cloning site, a packaging se-
quence (PS), and a terminator of ssDNA synthesis (M13term) containing ssDNA termination site T1 and ssDNA start site S2. The M13term sequence was adapted from
the M13ori sequence by selectively deactivating the S2 ssDNA initiation function. (B) The ssDNA synthesis initiation and termination functions of the origin overlap
near the c and d regions that form an inverted repeat (highlighted in gray). Therefore, we used a mutational screen of the d region to optimize the M13term perfor-
mance. (C) Three primary species were observed: S1T2, representing failed termination at terminator T1, S2T2, representing spurious initiation at initiator S2, and
S1T1, the desired product. (D) We analyzed the variants by agarose gel. Substituting 0–2 thymines yielded the S2T2 species (*). Substituting 4–6 bases yielded the S1T2
species (**). Substituting three thymines yielded the best balance between spurious S2 initiation and failed T1 termination, producing the most pure S1T1 species (***).
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(26). Our goal was to focus on optimizing the terminator region
while minimizing any off-target initiation, so we reasoned that
the shortened fragment would serve as a good starting point.
We then focused on optimizing the T1-S2 region (Figure 2B) to
reduce unwanted initiation at S2, while maintaining T1 termi-
nation function. In the filamentous phage propagation, the
plus-strand (i.e. phage-exported strand) ssDNA synthesis occurs
by rolling-circle amplification starting at a single-stranded
break created by gpII, a multi-function phage protein which also
mediates unwinding, replication and termination by cleaving
and circularizing the amplified strand (26). We focused on the c
and d regions (Figure 2B, highlighted in grey) which are known
binding sites for gpII where the termination and initiation func-
tions overlap. We performed a mutational screen starting at the
30 end of the d region, near the site of the Specthrie et al. D29
truncation (Figure 2B, blue label). We cloned variants of the
phagemid with up to six d-region bases substituted with thy-
mines (T), except for one thymine base which we replaced with
adenine (Figure 2B). We tested ssDNA production of each vari-
ant in Escherichia coli culture co-infected with helper phage.
Three ssDNA species were observed: the target species S1T1,
and off-target species S1T2 and S2T2 (Figure 2C). We observed
that 0-, 1-, or 2-base substitutions permitted ssDNA initiation,
leading to synthesis of an S2T2 off-target species of ssDNA.
Meanwhile, 4-, 5- or 6-base substitutions interfered with ssDNA
termination, leading to an alternate S1T2 off-target ssDNA spe-
cies (Figure 2D). We achieved the best balance between target
(S1T1) and off-target (S1T2 and S2T2) ssDNA species using the
3-base substitution. When we analyzed the gel with ImageJ, we
found the 3-base substitution produced off-target S1T2 and
S2T2 bands with 3% and 1% the integrated density of the target
S1T1 band, respectively. In comparison, the 2-base substitution
produced a S2T2 species with 7% the integrated density of the
S1T1 band, while the 4-base substitution produced a S1T2 band
with 8% of the integrated density of the S1T1 band. We subse-
quently used the 3-base substitution in all pScaf constructs.
3.2 Custom scaffolds and test origami
We created custom scaffolds with lengths of 1512, 2268, 3024,
5544, 8064 and 10080 bases (Figure 3, Supplementary Figure S2).
Each scaffold was verified by sequencing and analyzed by aga-
rose gel electrophoresis. We used ImageJ to estimate that the
purity of correct-length scaffold products ranged from 46% to
83% of total integrated intensity of the sample lane (Figure 3C).
We used Cadnano (27) to design a series of DNA origami shapes
that approximate rectangular cuboids or brick-like structures.
We folded the resulting DNA origami shapes and visualized
them using agarose gel electrophoresis and negative stain TEM
(Figure 4 and Supplementary Data S4–S10). When analyzed for
purity with ImageJ, the leading gel bands representing the
folded structures ranged from 68% to 83% of the total integrated
intensity of the sample lane (Figure 4A). We assessed the folding
quality of the shapes by manual counting of particles in the
TEM micrographs. We considered a particle to be well folded if
it appeared intact with no obvious defects, kinks, missing heli-
ces or aggregation. We estimated that 76% to 90% of all shapes
were well folded.
3.3 One-pot folding of multi-scaffold assemblies
The ability to synthesize custom scaffolds with relatively little
sequence overlap affords the possibility of folding DNA origami
from multiple scaffolds in a one-pot reaction. To validate this
concept, we designed a six-helix-bundle nanotube comprised of
three scaffolds with lengths of 1512, 2268 and 3024 bases. These
Figure 3. Cloning scheme and gel analysis of new scaffolds. (A) Custom sequence inserts are PCR-amplified with a forward primer containing KpnI and BglII sites and
reverse primer containing a BamHI site. Inserts up to 3 kb in length were directly transformed into E. coli bearing helper plasmid. Larger scaffolds can be assembled by
iterative PvuIþBamHI digestion of the vector containing the 50 fragment, and PvuIþBglII digestion of the vector containing the 30 fragment, followed by ligation, trans-
formation and miniprep. (B) Twelve inserts (A–L) were cloned into pScaf vector at the KpnI-BamHI site. Inserts A, B and C were used to produce scaffolds with lengths
of 1512, 2268 and 3024 bases. Larger scaffolds were assembled in multiple rounds as shown. (C) All scaffolds were grown in XL1-Blue cells containing helper plasmid
M13cp, recovered and analyzed by agarose gel electrophoresis to determine purities ranging from 46% to 83%.
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scaffold sequences are unique and derived from the same plas-
mid (see Supplementary Figure S2). The scaffolds were folded in
a one-pot reaction both with and without connector staples to
join them into a single nanotube.
4. Discussion
Our approach has significant advantages over pre-existing
methods for making custom scaffolds to build DNA origami
nanostructures. First, we have demonstrated that custom scaf-
folds can be generated with lengths of up to 10 kb. Thus, the
method is compatible with nearly all origami shapes that have
been published to date and will enable the creation of additional
large shapes. Second, although cloning large (>3 kb) custom in-
sert sequences into phagemids presents difficult challenges,
the cloning scheme we report here circumvents some of them.
We found the insertion of long sequences is much more reliable
with a multi-step assembly approach that cuts the antibiotic re-
sistance gene during each round and includes a positive selec-
tion for full-length constructs that reconstitute the gene. Earlier,
when we attempted to clone several 7–8 kb PCR-amplified
inserts in a single round without splitting the antibiotic resis-
tance gene, we typically needed to screen 36 colonies at a time
to observe 5–8% transformation efficiency. Once we imple-
mented the multi-step scheme, our transformation efficiency
improved to 80–100% when screening five colonies per round.
Third, because we rely on phagemids to grow custom scaffolds
in E. coli, the method is compatible with techniques that can be
scaled to produce milligram-scale quantities of custom scaf-
folds using flasks and a shaker-incubator. Moreover, bacterial
production offers a potentially reliable and feasible method for
scaling up production to much larger quantities using bioreac-
tors, as has been demonstrated for other scaffolds (20, 28).
We PCR-amplified 12 unique custom insert sequences from
two different plasmids (Supplementary Figure S2) and incorpo-
rated them into the pScaf vector. We used multiple rounds of
restriction and ligation to concatenate nine of these sequences
into larger inserts as shown in Figure 3B, producing an addi-
tional six inserts. We did not observe any particular constraints
on the sequences that can be incorporated into custom scaf-
folds using our method, with the caveat that we have only
tested a limited number of sequence inserts from plasmid sour-
ces. Like any approach that requires cloning, our method is
likely to encounter challenges with highly repetitive or low-
complexity sequence inserts.
With our method, it will now be possible to rapidly generate
large DNA origami shapes with highly customized scaffold
sequences. We recognized the need for easier methods to make
custom scaffolds when making DNA origami shapes that fold
from limited sets of reusable staple sequences (29). For conve-
nience, we incorporated sequences from pre-existing sources
that we already had on hand [pFastBac-green fluorescent protein
(GFP)-dynein-2(D1091–Q4307) plasmid and the bacteriophage
Lambda genome, see Supplementary Figure S2]. Additional scaf-
folds of custom length can be generated quickly using a similar
approach. Sequences also might be ordered from gene synthesis
vendors and combined with our approach to generate scaffolds
tailored for answering specific questions about DNA origami de-
sign principles, or to incorporate protein-binding sites.
Our scaffold lengths were chosen for convenience of design-
ing DNA origami shapes using the honeycomb lattice architec-
ture, which assumes B-form DNA with 34.3 mean twist per
Figure 4. Folding custom scaffolds into DNA origami shapes and assemblies. Six scaffolds of varying sizes were folded into DNA origami shapes and assemblies.
Folding reactions were analyzed by gel electrophoresis, and origami analyzed negative stain transmission electron microscopy. (A) Brick-like DNA origami shapes were
folded from scaffolds of lengths 1512, 2268, 3024, 5544, 8064 and 10080 bases. Each brick was PEG-purified and imaged by negative stain TEM. Class averages for each
brick are shown, along with a 20-nm scale bar. (B) Scaffolds of lengths 1512, 2268 and 3024 were folded separately into six-helix-bundle (6hb) nanotubes. All three scaf-
folds and 6hb-staple sets were combined into one-pot reaction mixtures. When connector staples are included, the three scaffolds assemble into a 6hb trimer. TEM
micrographs of the individual 6hb nanotubes and combined trimer are shown with 100-nm scale bars.
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base, or 21 base pairs every two turns (6). In practice, circular
scaffolds whose lengths are divisible by 42 are useful for creat-
ing shapes without any unused bases, and so we designed scaf-
folds as multiples of 42, i.e. 36 42¼ 1512, 72 42¼ 3024,
132 42¼ 5044, 192 42¼ 8064, 240 42¼ 10080.
Custom scaffolds will be useful for studying the DNA origami
method itself. For example, new scaffolds can be used to exam-
ine sequence-level determinants of folding yield. Sequences of
particular base compositions (high-guanine-cytosine, high-
adenine-thymine, 3-letter alphabets) with well-defined repeti-
tion or self-complementarity can be constructed and used to
test hypotheses explaining the role of melting temperature or
secondary structure in origami folding. Additionally, custom
scaffolds can have practical benefits for routine origami design.
We have often desired to create large DNA origami shapes with
specific custom sequences at multiple non-contiguous locations
within the scaffold. Generating these custom scaffolds is now
much easier compared to cloning large inserts directly into
M13mp18 in a single step.
It is also useful to be able to produce multiple unique scaf-
folds with very little sequence overlap. Sets of multiple unique
custom sequences can be used for facile one-pot assembly of
multimeric asymmetric structures. We demonstrated the one-
pot assembly of small six-helix-bundle nanotube shapes and
expect our approach can extend to reliably making larger
shapes. Multi-scaffold DNA origami will enable to creation of
assemblies with larger uniquely addressable surface areas
when compared to single scaffold DNA origami. Larger assem-
blies will increase the maximum distances between unique
modifications such as protein or nanoparticle attachments.
While future studies will be needed to determine how much se-
quence overlap can be tolerated in multi-scaffold assemblies of
DNA origami, we expect it should now be possible to design
three custom 10-kb scaffolds to assemble into an asymmetric
30 kb origami in which nearly the entire structure is uniquely
addressable, which could prove beneficial for certain
applications.
Before we settled on the pScaf design, we attempted to gen-
erate custom scaffolds using a phagemid with a terminator
based on the D29 truncation used by Specthrie et al. (3). Our
observations of an off-target ssDNA species led us to attempt to
optimize the terminator sequence. To guide our approach and
select the site for our mutational screen, we reviewed previous
studies of the initiation and termination of filamentous phage
plus-strand synthesis (2, 26, 30). We were fortunate to find a se-
quence that seems to reduce the initiation function of gpII while
retaining its termination function, though we lack a mechanis-
tic understanding of why our variant gave better results. We
also do not know the sources of trace amounts of off-target
ssDNA that is produced in addition to our scaffolds (i.e. the faint
extra bands and smearing in Figure 3C). A better understanding
of the fundamental biology of filamentous phages could lead to
further improvements in custom scaffold production with
phagemids derived from pScaf. For example, a better under-
standing of how DNA sequence and structure in the vicinity of
the termination site affect production of off-target ssDNA prod-
ucts can help us engineer an improved pScaf system with no
off-target species.
Although the TTT terminator variant greatly improved the
scaffold purity, we were not able to completely eliminate in-
complete termination or spurious initiation in our scaffold
preps. We also observed some prep-to-prep variation in total
scaffold yield and purity and production of off-target species
when using the helper plasmid (Supplementary Figure S3). We
typically screened 4 to 5 colonies of XL1-Blue-Helper trans-
formed with each pScaf variant and retained the transformant
with the best purity. Our maximum purity is similar to commer-
cially available M13-derived scaffold (31). Our DNA origami gel
analysis and TEM images show that we obtained a relatively ho-
mogeneous population of folded origami structures, so the cur-
rent levels of purity will be suitable for many applications.
The sequence insertion locus used KpnI and BamHI restric-
tion sites, which would need modification if those sites are to
be incorporated into a custom scaffold. A multiple cloning site
would provide greater flexibility for cloning sequence inserts.
We did not attempt to reduce the size of the terminator region
that is incorporated into the scaffold ssDNA, so a further reduc-
tion in size of the fixed region of 393 bases may be possible with
additional optimization. While we produced scaffolds up to
10 kb in length, we note that this length does not represent an
upper limit. We have not yet attempted to make longer scaf-
folds, but it should be possible following our scheme.
In summary, we have developed and validated a novel phag-
emid, pScaf, for creating highly customized ssDNA DNA origami
scaffolds of 10-kb lengths that can be produced with techniques
compatible with milligram-scale yields. Our approach removes
a longstanding constraint that has held back progress in the use
of large DNA origami scaffolds, which is that researchers have
had to rely on the genome of M13 phage which cannot be easily
customized. The ability to generate many long, unique custom
scaffolds will enable researchers to resolve many unanswered
questions about what the optimal methods are to create and de-
sign DNA origami sequences, how to easily incorporate func-
tional sequences, such as protein-binding sites, into multiple
sites within each shape, and how to better adapt these methods
in future applications.
Availability
Plasmids have been deposited at AddGene (https://www.addg
ene.org/). SnapGene files, custom scaffold sequences, Cadnano
source files and DNA origami staple sequences available at
https://github.com/douglaslab/pScaf.
Accession Numbers
Nucleotide sequences for the pScaf vector and custom sequence
inserts used to make the reported scaffolds have been deposited
in GenBank under the accession numbers: MH319458,
MH319459, MH319460, MH319461, MH319462, MH319468 and
MH319473.
Supplementary data
Supplementary Data are available at SYNBIO online.
Acknowledgements
We thank P. Rothemund and L. Bienen for comments on the
manuscript. We are grateful to A. Bradbury for providing the
M13cp helper plasmid.
Funding
Army Research Office [W911NF-14-1-0507]; Del E. Webb
Foundation p13-2-28]; and National Science Foundation
[CCF-1317640]; T.A. holds a Ruth L. Kirschstein NRSA
P.M. Nafisi et al. | 7
Postdoctoral Fellowship (F32GM119322); S.M.D. holds a
Career Award at the Scientific Interface from the Burroughs
Wellcome Fund (1010247). Funding for open access charge:
Army Research Office.
Conflict of interest statement. None declared.
References
1. Rothemund,P.W.K. (2006) Folding DNA to create nanoscale
shapes and patterns. Nature, 440, 297–302.
2. Dotto,G.P., Horiuchi,K. and Zinder,N.D. (1982) Initiation and
termination of phage f1 plus-strand synthesis. Proc. Natl.
Acad. Sci. U. S. A., 79, 7122–7126.
3. Specthrie,L., Bullitt,E., Horiuchi,K., Model,P., Russel,M. and
Makowski,L. (1992) Construction of a microphage variant of
filamentous bacteriophage. J. Mol. Biol., 228, 720–724.
4. Pinheiro,A.V., Han,D., Shih,W.M. and Yan,H. (2011)
Challenges and opportunities for structural DNA nanotech-
nology. Nat. Nanotechnol., 6, 763–772.
5. Pound,E., Ashton,J.R., Becerril,H.A. and Woolley,A.T. (2009)
Polymerase chain reaction based scaffold preparation for the
production of thin, branched DNA origami nanostructures of
arbitrary sizes. Nano Lett., 9, 4302–4305.
6. Douglas,S.M., Dietz,H., Liedl,T., Ho¨gberg,B., Graf,F. and
Shih,W.M. (2009) Self-assembly of DNA into nanoscale
three-dimensional shapes. Nature, 459, 414–418.
7. Zhang,H., Chao,J., Pan,D., Liu,H., Huang,Q. and Fan,C. (2012)
Folding super-sized DNA origami with scaffold strands from
long-range PCR. Chem. Commun., doi: 10.1039/c2cc32204h.
8. Yang,Y., Han,D., Nangreave,J., Liu,Y. and Yan,H. (2012) DNA
origami with double-stranded DNA as a unified scaffold. ACS
Nano, 6, 8209–8215.
9. Zadegan,R.M., Jepsen,M.D.E., Thomsen,K.E., Okholm,A.H.,
Schaffert,D.H., Andersen,E.S., Birkedal,V. and Kjems,J. (2012)
Construction of a 4 zeptoliters switchable 3D DNA box ori-
gami. ACS Nano, 6, 10050–10053.
10.Ducani,C., Kaul,C., Moche,M., Shih,W.M. and Ho¨gberg,B. (2013)
Enzymatic production of ‘monoclonal stoichiometric’
single-stranded DNA oligonucleotides. Nat.Methods, 10, 647–652.
11.Marchi,A.N., Saaem,I., Tian,J. and LaBean,T.H. (2013) One-pot
assembly of a hetero-dimeric DNA origami from chip-derived
staples and double-stranded scaffold. ACS Nano, 7, 903–910.
12.Said,H., Schu¨ller,V.J., Eber,F.J., Wege,C., Liedl,T. and Richert,C.
(2013) M1.3—a small scaffold for DNA origami. Nanoscale, 5,
284–290.
13.Li,W., Yang,Y., Jiang,S., Yan,H. and Liu,Y. (2014) Controlled
nucleation and growth of DNA tile arrays within prescribed
DNA origami frames and their dynamics. J. Am. Chem. Soc.,
136, 3724–3727.
14.Nickels,P.C., Ke,Y., Jungmann,R., Smith,D.M.,
Leichsenring,M., Shih,W.M., Liedl,T. and Ho¨gberg,B. (2014)
DNA origami structures directly assembled from intact bac-
teriophages. Small, 10, 1765–1769.
15.Marchi,A.N., Saaem,I., Vogen,B.N., Brown,S. and LaBean,T.H.
(2014) Toward larger DNA origami. Nano Lett., 14, 5740–5747.
16.Erkelenz,M., Bauer,D.M., Meyer,R., Gatsogiannis,C.,
Raunser,S., Sacca`,B. and Niemeyer,C.M. (2014) A Facile
Method for Preparation of Tailored Scaffolds for
DNA-Origami. Small, 10, 73–77.
17.Brown,S., Majikes,J., Martı´nez,A., Giro´n,T.M., Fennell,H.,
Samano,E.C. and LaBean,T.H. (2015) An easy-to-prepare min-
i-scaffold for DNA origami. Nanoscale, 7, 16621–16624.
18.Veneziano,R, Ratanalert,S., Zhang,K, Zhang,F., Yan,H,
Chiu,W. and Bathe,M. (2016) Designer nanoscale DNA assem-
blies programmed from the top down. Science, doi:
10.1126/science.aaf4388.
19.Krieg,E. and Shih,W.M. (2018) Selective nascent polymer
catch-and-release enables scalable isolation of
multi-kilobase single-stranded DNA. Angew. Chem. Int. Ed.
Engl., 57, 714–718.
20.Kick,B., Praetorius,F., Dietz,H. and Weuster-Botz,D. (2015)
Efficient production of single-stranded phage DNA as scaf-
folds for DNA origami. Nano Lett., 15, 4672–4676.
21.Sambrook,J Russell,D.W, (2001) Molecular Cloning: A Laboratory
Manual, 3rd edn. Cold Spring Harbor Laboratory Press, New York.
22.Messing,J. (1983) New M13 vectors for cloning. Methods
Enzymol., 101, 20–78.
23.Shih,W.M., Quispe,J.D. and Joyce,G.F. (2004) A 1.7-kilobase
single-stranded DNA that folds into a nanoscale octahedron.
Nature, 427, 618–621.
24.Chasteen,L., Ayriss,J., Pavlik,P. and Bradbury,A.R.M. (2006)
Eliminating helper phage from phage display. Nucleic Acids
Res., 34, e145.
25.Aksel,T., Majumdar,A. and Barrick,D. (2011) The contribution
of entropy, enthalpy, and hydrophobic desolvation to cooper-
ativity in repeat-protein folding. Structure, 19, 349–360.
26.Horiuchi,K. (1997) Initiation mechanisms in replication of fil-
amentous phage DNA. Genes Cells, 2, 425–432.
27.Douglas,S.M., Marblestone,A.H., Teerapittayanon,S.,
Vazquez,A., Church,G.M. and Shih,W.M. (2009) Rapid proto-
typing of 3D DNA-origami shapes with caDNAno. Nucleic
Acids Res., 37, 5001–5006.
28.Praetorius,F., Kick,B., Behler,K.L., Honemann,M.N., Weuster-
Botz,D. and Dietz,H. (2017) Biotechnological mass production
of DNA origami. Nature, 552, 84.
29.Niekamp,S., Blumer,K., Nafisi,P.M., Tsui,K., Garbutt,J. and
Douglas,S.M. (2016) Folding complex DNA nanostructures
from limited sets of reusable sequences. Nucleic Acids Res., 44,
e102.
30.Dotto,G.P. and Horiuchi,K. (1981) Replication of a plasmid
containing two origins of bacteriophage f1. J. Mol. Biol., 153,
169–176.
31.Kuzyk,A., Yang,Y., Duan,X., Stoll,S., Govorov,A.O.,
Sugiyama,H., Endo,M. and Liu,N. (2016) A light-driven three-
dimensional plasmonic nanosystem that translates molecu-
lar motion into reversible chiroptical function. Nat. Commun.,
7, 10591.
8 | Synthetic Biology, 2018, Vol. 3, No. 1
